Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Armata Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −1 vs. Q2 2025
- Shares held
- 759.7K
- +24.5K (+3.3%) vs. Q2 2025
- Total value
- $2.27M
- +$875.4K (+62.7%) vs. Q2 2025
- New holders
- 2
- 4 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 53 | $32.3M |
| Q1 2026 | 45 | $40.2M |
| Q4 2025 | 36 | $7.85M |
| Q3 2025 | 28 | $2.27M |
| Q2 2025 | 29 | $1.40M |
| Q1 2025 | 26 | $1.08M |
| Q4 2024 | 24 | $2.57M |
| Q3 2024 | 24 | $3.28M |
| Q2 2024 | 23 | $3.86M |
| Q1 2024 | 24 | $5.93M |
| Q4 2023 | 25 | $4.17M |
| Q3 2023 | 23 | $3.85M |
| Q2 2023 | 22 | $1.35M |
| Q1 2023 | 23 | $2.06M |
| Q4 2022 | 26 | $1.61M |
| Q3 2022 | 20 | $5.73M |
| Q2 2022 | 19 | $5.25M |
| Q1 2022 | 20 | $6.61M |
| Q4 2021 | 17 | $7.25M |
| Q3 2021 | 20 | $4.32M |
| Q2 2021 | 21 | $4.59M |
| Q1 2021 | 23 | $5.62M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Armata Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 297,038 | $885.2K | 0.00% | +36,965+14.2% | Added |
| Geode Capital Management, LLC | 104,546 | $311.6K | 0.00% | 00.0% | Unchanged |
| Edgewood Management LLC | 100,000 | $298.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 44,682 | $133.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 41,296 | $123.1K | 0.00% | +2,400+6.2% | Added |
| State Street Corp | 40,300 | $120.1K | 0.00% | 00.0% | Unchanged |
| SeaCrest Wealth Management, LLC | 34,954 | $112.6K | 0.01% | 00.0% | Unchanged |
| GSB Wealth Management, LLC | 30,000 | $89.4K | 0.02% | 00.0% | Unchanged |
| BlackRock, Inc. | 26,666 | $79.5K | 0.00% | +748+2.9% | Added |
| Northern Trust Corp | 19,273 | $57.4K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 13,140 | $39.2K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,000 | $8.94K | 0.00% | 00.0% | Unchanged |
| Cornerstone National Bank & Trust Co | 1,428 | $4.25K | 0.00% | 00.0% | Unchanged |
| Measured Wealth Private Client Group, LLC | 1,000 | $2.98K | 0.00% | +1,000 | New |
| Trifecta Capital Advisors, LLC | 714 | $2.13K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 571 | $1.70K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 457 | $1.36K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 355 | $1.06K | 0.00% | −1,350−79.2% | Reduced |
| Salem Investment Counselors Inc | 100 | $298 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 71 | $212 | 0.00% | 00.0% | Unchanged |
| Team Financial Group, LLC | 71 | $212 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 44 | $131 | 0.00% | +43+4,300.0% | Added |
| JPMorgan Chase & Co | 24 | $72 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7 | $21 | 0.00% | −96−93.2% | Reduced |
| Barclays PLC | 6 | $18 | 0.00% | +6 | New |
| SBI Securities Co., Ltd. | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $6 | 0.00% | −107−98.2% | Reduced |
| Wells Fargo & Company | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,104−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |